tirzepatide approval date shows 47% greater weight loss vs. Wegovy Tirzepatide Dosing Chart 2026: 2.5-15

This study aimed to compare durability of treatment efficacy of once-weekly (OW) semaglutide for T2D with that of the dipeptidyl peptidase 4 inhibitor (DPP4i) class

Kisspeptin shows real promise for ovulation induction

Tirzepatide dosing begins low and increases gradually over weeks to find your optimal therapeutic level

Discover personalized solutions for a healthier, happier you

Exaggerated GLP-1 secretion underlies hyperinsulinemic #hypoglycemia in some individuals post #bariatric surgery and contributes to improved beta cell function

The monotherapy group had a difference in HbA1c % from baseline of 0.14% vs -0.9% in the combination group (p=0.007)